Prestige Consumer Healthcare Inc. (PBH)

Pharmaceutical Preparations

Latest Price

$47.39

TTM P/E

13.27

Normalized P/E

16.87

TTM Div Yield

Fwd Div Yield

Book Value

40.38

P/B Ratio

1.17

Valuation metrics

EPS: $3.91

Book value / share: $39.89

Formula: √(22.5 × EPS × BVPS)

Graham Number

$59.24

+25% upside

Norm. op. income: $309M (median of 7yr)

Tax rate: 24%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$29.83

37% downside

Base FCF: $243M (median of recent 5yr)

Growth: 3%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$58.74

+24% upside

EPS: $3.91

Target P/E: 17×

Formula: EPS × P/E

P/E Fair Value

$66.47

+40% upside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	7.83M	$370.0M	16.53%	+442.8K	2026-06-30
Ariel Investments, LLC	4.87M	$230.0M	10.28%	+594.4K	2026-06-30
Vanguard Portfolio Management LLC	2.83M	$133.0M	5.96%	+21.5K	2026-06-30
Dimensional Fund Advisors LP	2.66M	$125.0M	5.62%	-11.5K	2026-06-30
Fuller & Thaler Asset Management, Inc.	2.33M	$110.0M	4.92%	--	2026-06-30
Vanguard Capital Management LLC	2.14M	$101.0M	4.51%	+44.0K	2026-06-30
State Street Corp	2.12M	$100.0M	4.47%	+145.5K	2026-06-30
Brandes Investment Partners, LP	2.05M	$96.0M	4.33%	+1.20M	2026-06-30
Kayne Anderson Rudnick Investment Management LLC	1.87M	$88.0M	3.95%	-330.6K	2026-06-30
Geode Capital Management, LLC	1.57M	$74.0M	3.32%	+111.7K	2026-06-30